FDA Approves Newest Antibody-Drug Conjugate for Cervical CancerByBryan Fitzgerald, PharmD, BCOP,Don V. Scigliano, PharmD CandidateJanuary 14th 2022Tisotumab vedotin-tftv is used as antitumor therapy for patients with disease progression during or after chemotherapy.